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NOTICE TO READERS
The American Institute of Certified Public Accountants has issued
a series of industry-oriented audit guides that present recommendations on auditing procedures and auditors' reports and, in some
instances, on accounting principles, and a series of accounting guides
that present recommendations on accounting principles. Based on
experience in the application of these guides, AICPA subcommittees
or task forces may from time to time conclude that it is desirable to
change a guide. A statement of position is used to revise or clarify
certain of the recommendations in the guide to which it relates. A
statement of position represents the considered judgment of the responsible AICPA subcommittee or task force.
To the extent that a statement of position is concerned with
auditing procedures and auditors' reports, its degree of authority is
the same as that of the audit guide to which it relates. As to such
matters, members should be aware that they may be called upon to
justify departures from the recommendations of the subcommittee or
task force.
To the extent that a statement of position relates to standards of
financial accounting or reporting (accounting principles), the recommendations of the subcommittee or task force are subject to ultimate
disposition by the Financial Accounting Standards Board. The recommendations are made for the purpose of urging the FASB to promulgate standards that the subcommittee or task force believes would be
in the public interest.
Subcommittee on Health Care Matters
A L B E R T A . CARDONE,

Chairman

RONALD B . ASHWORTH

DAVID M . T U R N E R
DAVID D . W I L L M A N

MARVIN E . B A K E R

AICPA Staff:

CHARLES K . BRADFORD

JOSEPH F . MORAGLIO,

JOHN E . B U E L T
EDWARD B . H I N K E R
H . CARLTON MOORE
BERNARD F . O ' N E I L , J R .
BERNARD H . ROSS
D A R W I N W . SCHLAG, J R .

Director
Federal Government Division

L Y S L E P . HOLLENBECK,

Senior Manager
Federal Government Division
ROBERT C . MULLINS, Manager
Federal Government Division

The subcommittee gratefully acknowledges the contributions made to
the development of this Statement of Position by former members of
the subcommittee, Robert A. Cerrone, William Freitag, and Robert F.
Rosenstiel.

AICPA

American Institute of Certified Public Accountants
1211 Avenue of the Americas, New York, N.Y.10036 (212) 575-6200

May 1, 1978
Donald J. Kirk, CPA
Chairman
Financial Accounting Standards Board
High Ridge Park
Stamford, Connecticut 06905
Dear Mr. Kirk:
The accompanying statement of position, prepared by the
AICPA Subcommittee on Health Care Matters, proposes
amendments to the AICPA Industry Audit Guide on
Audits of Hospitals. The statement of position will
amend part of chapter 2 of the guide which deals with
investment income and gains (losses).
Members of the subcommittee will be glad to meet with
you or your representatives to discuss this proposal.
The subcommittee would also appreciate being advised as
to the board's proposed action on its recommendations.
Sincerely yours,

Albert A. Cardone, Chairman
Subcommittee on Health
Care Matters
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Accounting by Hospitals for
Certain Marketable Equity Securities
Statement of Financial Accounting Standards no. 12, Accounting
for Certain Marketable Securities, issued by the Financial Accounting Standards Board, states in the first sentence of paragraph 5 that it "does not apply to not-for-profit organizations,"
which are those described in the Introduction to Accounting Research Bulletin no. 43. Thus, FASB Statement no. 12 applies to
investor-owned hospitals and does not apply to not-for-profit
hospitals.
The AICPA Subcommittee on Health Care Matters believes
that the Hospital Audit Guide should be amended by deletion of
the section "Investment Income and Gains (Losses)" and inclusion of the following new section.
Accounting for Certain Marketable Equity Securities
Investor-owned hospitals are subject to the requirements of
FASB Statement no. 12 and interpretations of that statement,
which specify the accounting and disclosure requirements applicable to portfolios of marketable equity securities. Under
statement no. 12, cost is no longer an acceptable accounting
method for marketable equity securities, and the carrying amount
of a marketable equity security portfolio that was previously
carried at cost should now be the lower of its aggregate cost
and market values.1
Similarly, cost should no longer be used by not-for-profit hospitals
for marketable equity securities. The carrying amount of a mar1

Reference should be made to paragraph 7 of FASB Statement no. 12 for
definitions of the following terms: equity security, marketable, market
price, market value, cost, valuation allowance, carrying amount, realized
gain or loss, net unrealized gain or loss.
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ketable equity security portfolio of a not-for-profit hospital that
was previously carried at cost should now be the lower of its
aggregate cost and market value, determined at the balance
sheet date. The amounts by which the aggregate cost of each
portfolio exceeds market value should be accounted for as valuation allowances.
Marketable equity securities owned by a not-for-profit hospital
should be grouped into separate portfolios, as indicated below, for
the purpose of comparing aggregate cost and market value to
determine carrying amount.
1. Marketable equity securities included in unrestricted funds
should be grouped into separate portfolios according to the
current or noncurrent classification of the securities.
2. Marketable equity securities included in different types of
restricted funds should be grouped into separate portfolios
according to types of funds (for example, portfolios of marketable equity securities included in various specific purpose
funds should be grouped together but not with those in endowment funds).
3. The current portfolios of unrestricted funds of entities that are
combined in financial statements should be treated as a single
combined portfolio; the noncurrent unrestricted portfolios of
those entities should also be treated as a single combined portfolio; similar restricted fund portfolios of entities that are
combined in financial statements should be treated as single
portfolios (for example, portfolios of marketable equity
securities included in the various specific purpose funds
of a not-for-profit hospital should be combined with the
portfolios of marketable equity securities held in the various
specific purpose funds of an entity whose financial statements
are combined with those of the not-for-profit hospital).
If there is a change in a marketable equity security's classification between current and noncurrent assets in unrestricted funds,
the security should be transferred between the corresponding portfolios at the lower of its cost and market values at the date of transfer. If market value is less than cost, the market value becomes
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the new cost basis, and the difference is accounted for as if it were
a realized loss and is included in the nonoperating revenues section of the statement of revenues and expenses.
Changes in the valuation allowance for a marketable equity
securities portfolio included in current assets in unrestricted funds
should be disclosed in the nonoperating revenues section of the
statement of revenues and expenses. Changes in the valuation
allowance for a marketable equity securities portfolio included in
noncurrent assets in unrestricted funds or assets in restricted funds
should be disclosed in the respective statements of changes in fund
balances; accumulated changes in the valuation allowance for such
portfolios should be disclosed in the appropriate fund balance in
the balance sheet.
If the hospital pools its investments (which could include investments of current and noncurrent unrestricted funds and investments of restricted funds), the cost of marketable equity
securities in the fund(s) should be compared to the allocation of
the market value of the pooled marketable equity securities for
purposes of implementing the above recommendations. To apply
those provisions properly, marketable equity securities and other
investments must be accounted for separately.
Income from investments of board-designated and other unrestricted funds and realized gains or losses on sales of investments
of board-designated and other unrestricted funds should be included in the statement of revenues and expenses as nonoperating
revenue of the period in which they are earned or incurred.
Realized gains or losses on the sale of investments of endowment funds should be added to or deducted from endowment
fund principal unless such amounts are legally available for other
use or chargeable against other funds. Investment income of those
funds should be accounted for in accordance with the donors'
instructions—for example, as resources for specific operating purposes if restricted, or nonoperating revenue if not.
Income and net realized gains or losses on investments of restricted funds other than endowment funds should be charged
or credited to the respective fund balance unless such amounts
are legally available for or chargeable against other funds. If such
amounts are legally available for unrestricted purposes, they should
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be included in nonoperating revenue. Gains or losses on investment trading between unrestricted and restricted funds and between various categories of restricted funds (for example, between
endowment and plant replacement funds) should be recognized
as realized gains or losses and separately disclosed in the financial
statements. Gains or losses resulting from transactions between
various board-designated funds of the unrestricted fund should
not be recognized.
The following information with respect to owned marketable
equity securities should also be disclosed either in the body of
the financial statements or in the accompanying notes:
1. As of the date of each balance sheet presented, aggregate cost
and market values for each separate portfolio into which marketable equity securities were grouped to determine carrying
amount, with identification of which is the carrying amount.
2. As of the date of the latest balance sheet presented, the following segregated by portfolio—
a. Gross unrealized gains representing the excess of market
value over cost for all marketable equity securities having
such an excess in the portfolio.
b. Gross unrealized losses representing the excess of cost over
market value for all marketable equity securities having
such an excess in the portfolio.
3. For each period for which a statement of revenues and expenses is presented—
a. Net realized gain or loss included in nonoperating revenue.
b. The basis on which cost was determined in computing realized gain or loss (average cost or other method).
The financial statements should not be adjusted for realized
gains, losses, or changes in market prices with respect to marketable equity securities if such gains, losses, or changes occur
after the date of the financial statements but before their issuance,
except for the situation covered in the following paragraph. However, significant net realized and net unrealized gains and losses
arising after the date of the financial statements but before their
issuance applicable to marketable equity securities owned at the
date of the most recent balance sheet should be disclosed.
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For those marketable securities for which the effect of a change
in carrying amount is included in the statement of changes in fund
balances rather than in the statement of revenues and expenses, a
determination should be made as to whether a decline in market
value below cost as of the balance sheet date of an individual
security is other than temporary. If the decline is judged to be
other than temporary, the cost basis of the individual security
should be written down to a new cost basis and the amount of the
write-down should be accounted for as a realized loss. The new
cost basis should not be changed for subsequent recoveries in
market value.
Unrealized gains or losses should not result in adjustment of
financial statements, except for changes in the valuation allowance related to marketable equity securities and for declines in
value that result from other than temporary impairment.
The disclosures in Note 1 to the sample financial statements on
page 48 of the Hospital Audit Guide should conform with the
disclosures set forth in this amendment.
Transition
The subcommittee recommends that this amendment be applied to financial statements for fiscal years beginning on or after
the first day of the first month following the date of this statement and encourages earlier application. If the initial application
of this statement requires the establishment of a valuation allowance, financial statements previously issued should not be restated.
If the establishment of a valuation allowance is required for a marketable equity securities portfolio included in current assets in unrestricted funds, the effect of the change should be included in the
determination of the excess of revenue over expense for the period
of the change in accordance with the provisions of APB Opinion
20. If the establishment of a valuation allowance is required for a
marketable equity securities portfolio included in noncurrent assets in unrestricted funds or assets in restricted funds, the effect of
the change should be presented in the statement of changes in
fund balance.
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